Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
580 participants
OBSERVATIONAL
2010-01-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary outcome: implantation and pregnancy rates
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Study of Three Different Embryo Transfer Media in ICSI Cycles
NCT02792673
Hyaluronan-enriched Medium and Euploid Blastocyst Transfers
NCT06165367
Hyaluronic Acid-enriched Transfer Medium in Single Blastocyst Transfer
NCT06492785
Hyaluronan-enriched Embryo Transfer Medium for Frozen-thawed Embryo Transfer
NCT02725827
Effect of Hyaluronan-enriched Medium on the Cumulative Ongoing Pregnancy Rate.
NCT04697823
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hyaluronan enriched transfer media
Embryos are incubated at least 10 minutes in hyaluronan enriched embryo transfer media before transfer
No interventions assigned to this group
Control group
Embryos are incubated in embryo transfer media containing low concentration of hyaluronan for at least 10 minutes before transfer
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* entering in vitro fertilization treatment
* at least 1 embryo transferred
Exclusion Criteria
* No embryo available for transfer
18 Years
48 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peter Fancsovits, Ph.D.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter Fancsovits, Ph.D.
Senior Clincial Embryologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Fancsovits, Ph.D.
Role: STUDY_CHAIR
Semmelweis University First Department of Obstetrics and Gynecology
Janos Urbancsek, MD, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Semmelweis University First Department of Obstetrics and Gynecology
Adam Lehner, MSc
Role: PRINCIPAL_INVESTIGATOR
Semmelweis University First Department of Obstetrics and Gynecology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Semmelweis University First Department of Obstetrics and Gynecology
Budapest, , Hungary
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bontekoe S, Heineman MJ, Johnson N, Blake D. Adherence compounds in embryo transfer media for assisted reproductive technologies. Cochrane Database Syst Rev. 2014 Feb 25;2014(2):CD007421. doi: 10.1002/14651858.CD007421.pub3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SemmelweisU-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.